V B Benard1, J Royalty, M Saraiya, T Rockwell, W Helsel. 1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Mailstop F-76, Atlanta, GA, 30341, USA, vdb9@cdc.gov.
Abstract
PURPOSE: To evaluate the effectiveness of a policy supporting early detection and prevention of cervical cancer among low-income and uninsured women by comparing women who reported never or rarely being screened (last screen >5 years) to those who reported screening in the past ≤5 years. METHODS: We analyzed data from 1,485,251 women who received their first Pap test in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) from July 2002 through June 2012. Of these, 461,893 women (31 %) reported being never or rarely screened and 1,023,358 (69 %) reported being screened in the past 5 years. Demographic (age, race/ethnicity, residence, and region) and clinic (cytologic and histologic results) characteristics were examined for the two groups. RESULTS: Women who were aged ≥50 years, Asian and Pacific Islander, American Indian or Alaska Native, multiracial, living in non-metro areas, or living in the South or a territory were more likely to report being never or rarely screened. The percentage of abnormal Pap tests and the rate of precancer and cancer (combined) was higher in the never or rarely screened group compared with the screened group (abnormal percentage: 2.9 vs 2.6 %, p value < 0.01; rate of precancer and cancer: 6.9 vs 3.7 per 1,000 women, p value < 0.01). CONCLUSIONS: The priority of reaching never or rarely screened women should continue since those women who entered the NBCCEDP not adequately screened had a greater prevalence of high-grade histological lesions and invasive cervical cancers at later stages than women screened more recently.
PURPOSE: To evaluate the effectiveness of a policy supporting early detection and prevention of cervical cancer among low-income and uninsured women by comparing women who reported never or rarely being screened (last screen >5 years) to those who reported screening in the past ≤5 years. METHODS: We analyzed data from 1,485,251 women who received their first Pap test in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) from July 2002 through June 2012. Of these, 461,893 women (31 %) reported being never or rarely screened and 1,023,358 (69 %) reported being screened in the past 5 years. Demographic (age, race/ethnicity, residence, and region) and clinic (cytologic and histologic results) characteristics were examined for the two groups. RESULTS:Women who were aged ≥50 years, Asian and Pacific Islander, American Indian or Alaska Native, multiracial, living in non-metro areas, or living in the South or a territory were more likely to report being never or rarely screened. The percentage of abnormal Pap tests and the rate of precancer and cancer (combined) was higher in the never or rarely screened group compared with the screened group (abnormal percentage: 2.9 vs 2.6 %, p value < 0.01; rate of precancer and cancer: 6.9 vs 3.7 per 1,000 women, p value < 0.01). CONCLUSIONS: The priority of reaching never or rarely screened women should continue since those women who entered the NBCCEDP not adequately screened had a greater prevalence of high-grade histological lesions and invasive cervical cancers at later stages than women screened more recently.
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young Journal: JAMA Date: 2002-04-24 Impact factor: 56.272
Authors: Wendy A Leyden; M Michele Manos; Ann M Geiger; Sheila Weinmann; Judy Mouchawar; Kimberly Bischoff; Marianne Ulcickas Yood; Joyce Gilbert; Stephen H Taplin Journal: J Natl Cancer Inst Date: 2005-05-04 Impact factor: 13.506
Authors: Elaine W Flagg; S Deblina Datta; Mona Saraiya; Elizabeth R Unger; Edward Peters; Lauren Cole; Vivien W Chen; Thomas Tucker; Mary Jane Byrne; Glenn Copeland; Won Silva; Meg Watson; Hillard Weinstock Journal: Cancer Causes Control Date: 2014-02-28 Impact factor: 2.506
Authors: Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon Journal: J Low Genit Tract Dis Date: 2007-10 Impact factor: 1.925
Authors: Gery P Guy; Florence K L Tangka; Ingrid J Hall; Jacqueline W Miller; Janet Royalty Journal: Cancer Causes Control Date: 2015-03-21 Impact factor: 2.506
Authors: Cary Suzanne Lea; Carolina Perez-Heydrich; Andrea C Des Marais; Alice R Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith Journal: J Womens Health (Larchmt) Date: 2019-03-15 Impact factor: 2.681
Authors: Jonah Musa; Chad J Achenbach; Linda C O'Dwyer; Charlesnika T Evans; Megan McHugh; Lifang Hou; Melissa A Simon; Robert L Murphy; Neil Jordan Journal: PLoS One Date: 2017-09-05 Impact factor: 3.240
Authors: Heling Bao; Lei Zhang; Limin Wang; Mei Zhang; Zhenping Zhao; Liwen Fang; Shu Cong; Maigeng Zhou; Linhong Wang Journal: Cancer Med Date: 2018-03-24 Impact factor: 4.452